This event is organized with the aim to help member companies in finding suitable business partner for collaboration as well as raising funds.

OUTLINE
Date:February 17, 2023(Fri)
Location:Shimadzu Tokyo Innovation Plaza(Kawasaki-city , Kanagawa, Japan)
Host :The Regenerative medicine & Cell therapy industrialization
network of Kanagawa (RINK) and Kanagawa Prefecture
Audience : RINK members(Big Pharma companies, Chemical companies,
Academia, Bank, Venture Capital, Local government etc.)
11:30-12:00 Opening Talk

Mr. Yoshiya Kakizaki , Osaka Sanitary Co., Ltd.
Mr. Ryohei Kokawa , Shimadzu Corporation
Ms. Akiko Yasaka , Tonomachi Lifescience Cluster Division
Ms. Haruka Yokoi , Kanagawa Prefecture Goverment
Mr. Kenichi Harada , RINK
Ms. Yuka Ikeda , Kanagawa Prefecture Goverment
12:00-13:50 Session A:The ambition of science and technology innovation to make dreams come true in ”Tonomachi”

Prof. Masaya Nakamura , Keio University
Dr. Shin Kawamata , Foundation for Biomedical Research and Innovation at Kobe
Dr.. Yoshimi Yashiro , Keio University
Dr. Yasunori Aizawa , Tokyo Institute of Technology
Mr. Ryuta Nomura , Central Institute for Experimental Animals
14:00-16:00 Session B:Greater Bio Community in Tokyo & Osaka

Mr. Kosuke Kawai , Iwatani Corporation
Ms. Haruka Hibino , Shonan iPark
Mr. Yukihiro Yamamoto , LINK-J
Dr, Hiroshi Atsumi , iCONM in collaboration with BioLabs
Mr. Jun Miyagawa , BiocK / SMBC
Dr. Maya Okamoto , PEIJ
Mr. Toshiyuki Nomura , Mitsui Fudosan
Mr. Kenichi Harada , RINK
16:15-17:45 Session C:What is important in evaluating cells – The role of “evaluation” in the industrialization of regenerative medicine –

Dr. Jun Kawai , KISTEC
Dr. Yoji Sato , National Institute of Health Sciences
Dr. Ryoji Ito , Central Institute for Experimental Animals
Dr. Yuji Komaki , Central Institute for Experimental Animals
Dr. Satoshi Yasuda , National Institute of Health Sciences
Dr. Yosuke Ozawa , Epistra
18:00-18:55 Session D:Overseas expansion of biotech startups

Dr. Ryo Hanamura , Arther D Little
Mr. Takanori Kuno , NERV
Ms. Suzuka Mouri , METI
Mr. Kenichi Harada , RINK
19:10-21:45 SessionE:Gathering of top runners in the regenerative medicine industry(SAMURAI Biotech Association・KRIC・RINK)

Dr. Ei Yamada , SAMURAI Biotech Association
Dr. Tadashi Matsumoto , SAMURAI Biotech Association
Mr. Takashi Suzuki , Shimadzu Corporation
Dr. Takeo Shimazaki , Ginrei Lab
Dr. Takehiko Kaneko , Heartseed
Mr. Atsushi Tsuchida , S-RACMO
Dr. Nobuhiko Kojima , Ecocell
Dr. Kaita Imai , Cytronics
Mr.Daiki Kawada , SANPLATEC
Mr. Tsubasa Matsui , JTEC Corporation
Mr. Taro Kobayashi , IKEDA SCIENTIFIC
Mr. Atsushi Fukuchi , SAMURAI Biotech Association
Mr.Hiroshi Kawashima , Kinki Bureau of METI
Ms. Haruka Yokoi , Kanagawa Prefecture Goverment